R. Nishimura

481 total citations
34 papers, 351 citations indexed

About

R. Nishimura is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, R. Nishimura has authored 34 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in R. Nishimura's work include Endometrial and Cervical Cancer Treatments (4 papers), Breast Cancer Treatment Studies (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). R. Nishimura is often cited by papers focused on Endometrial and Cervical Cancer Treatments (4 papers), Breast Cancer Treatment Studies (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). R. Nishimura collaborates with scholars based in Japan, United States and Iran. R. Nishimura's co-authors include J.U. Schlegel, Susumu Kanzaki, Keiichi Hanaki, Masanobu Fujimoto, Y. Kawashima, Shigeki Yamaguchi, Eiji Nanba, Junzo Kigawa, Seiichi Takekida and Yoshihiro Miyahara and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Experimental Biology and Medicine.

In The Last Decade

R. Nishimura

28 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Nishimura Japan 11 99 85 80 66 60 34 351
Kaifa Tang China 11 155 1.6× 44 0.5× 33 0.4× 38 0.6× 49 0.8× 36 351
Erhan Onuk Türkiye 14 112 1.1× 80 0.9× 184 2.3× 29 0.4× 42 0.7× 31 485
Sajini Elizabeth Jacob India 13 50 0.5× 35 0.4× 67 0.8× 28 0.4× 32 0.5× 42 375
Koray Erten Türkiye 8 96 1.0× 54 0.6× 57 0.7× 43 0.7× 77 1.3× 17 311
I F Hunt United States 8 118 1.2× 39 0.5× 38 0.5× 110 1.7× 11 0.2× 11 443
Shuyi Li China 11 83 0.8× 55 0.6× 52 0.7× 18 0.3× 29 0.5× 42 355
Paolo Camboni Italy 7 121 1.2× 77 0.9× 32 0.4× 79 1.2× 60 1.0× 7 369
Meng Hua Tao United States 14 192 1.9× 94 1.1× 42 0.5× 30 0.5× 12 0.2× 17 446
De‐Xin Yu China 11 185 1.9× 40 0.5× 33 0.4× 55 0.8× 79 1.3× 17 494

Countries citing papers authored by R. Nishimura

Since Specialization
Citations

This map shows the geographic impact of R. Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Nishimura more than expected).

Fields of papers citing papers by R. Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Nishimura. The network helps show where R. Nishimura may publish in the future.

Co-authorship network of co-authors of R. Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of R. Nishimura. A scholar is included among the top collaborators of R. Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Nishimura. R. Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Okuno, Keisuke, R. Nishimura, Hitoshi Sano, et al.. (2019). Juvenile Granulosa Cell Tumor with Elevated Peripheral Interleukin-6 Level Shows Prolonged Fever and Delayed Puberty. Yonago acta medica. 62(3). 263–267. 2 indexed citations
3.
Fujimoto, Masanobu, Y. Kawashima, Kenji Fukushima, et al.. (2017). Increased IRS2 mRNA Expression in SGA Neonates: PCR Analysis of Insulin/IGF Signaling in Cord Blood. Journal of the Endocrine Society. 1(12). 1408–1416. 4 indexed citations
4.
Fujimoto, Masanobu, Shinichi Okada, Y. Kawashima, et al.. (2014). Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan.. PubMed. 57(2). 85–91. 22 indexed citations
6.
Kinoshita, T., Norikazu Masuda, Yasuaki Sagara, et al.. (2011). Neoadjuvant anastrozole or tamoxifen for premenopausal breast cancer: Ki67 expression data from the STAGE study.. Journal of Clinical Oncology. 29(15_suppl). 501–501. 1 indexed citations
7.
Kawashima, Y., Shogo Okada, Nariaki Fujimoto, et al.. (2010). P75 Mutated IGF-I receptor (D1105E) extinguish autophosphorylation: A family of short stature born intrauterine growth retardation bearing a novel missense mutation of the IGF-I receptor. Growth Hormone & IGF Research. 20. S66–S66. 1 indexed citations
8.
Shimada, Muneaki, Junzo Kigawa, R. Nishimura, et al.. (2009). Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy after radical surgery: SGSG/TGCU Intergroup Surveillance. Journal of Clinical Oncology. 27(15_suppl). 5585–5585. 1 indexed citations
9.
Nishimura, R., et al.. (2008). Premenopausal status reflects an unfavorable prognosis in triple-negative breast cancer. Journal of Clinical Oncology. 26(15_suppl). 22208–22208. 2 indexed citations
10.
Nishimura, R., et al.. (2008). Is triple negative a prognostic factor in breast cancer?. European Journal of Cancer Supplements. 6(7). 87–87. 2 indexed citations
11.
Tanaka, Takahiro, Yoshio Maeno, Yoshihiro Miyahara, et al.. (2007). Radiotherapy negates the effect of retroperitoneal nonclosure for prevention of lymphedema of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey. International Journal of Gynecological Cancer. 17(2). 460–464. 32 indexed citations
13.
Fujiwara, Keiichi, Junzo Kigawa, Koh Hasegawa, et al.. (2003). Effect of simple omentoplasty and omentopexy in the prevention of complications after pelvic lymphadenectomy. International Journal of Gynecological Cancer. 13(1). 61–66. 31 indexed citations
14.
Fujiwara, Keiichi, Junzo Kigawa, Koh Hasegawa, et al.. (2003). Effect of simple omentoplasty and omentopexy in the prevention of complications after pelvic lymphadenectomy. International Journal of Gynecological Cancer. 13(1). 61–66. 9 indexed citations
15.
Nishimura, R., et al.. (1999). Filgrastim (r-metHuG-CSF) and its potential use in the reduction of radiation-induced oropharyngeal mucositis: an interim look at a randomized, double-blind, placebo-controlled trial.. PubMed. 5(3). 175–80. 24 indexed citations
16.
Shimizu, Takashi, et al.. (1992). Antenatal diagnosis of prune belly syndrome. Archives of Gynecology and Obstetrics. 251(4). 211–214. 7 indexed citations
17.
Schmidt, B J, et al.. (1978). Tay-Sachs Disease Heterozygote Selection. Pediatric Research. 12(10). 1029–1029. 1 indexed citations
18.
Schlegel, J.U., et al.. (1969). Studies in the Etiology and Prevention of Bladder Carcinoma. The Journal of Urology. 101(3). 317–324. 17 indexed citations
19.
Schlegel, J.U., et al.. (1969). Inhibitory Effect of L-Ascorbate on Tumor Formation in Urinary Bladders Implanted with 3-Hydroxyanthranilic Acid. Experimental Biology and Medicine. 131(2). 522–524. 36 indexed citations
20.
Nishimura, R., et al.. (1967). Stabilization of Urinary 3-Hydroxyanthranilic Acid by Oral Administration of L-Ascorbic Acid.. Experimental Biology and Medicine. 126(3). 702–704. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026